Valuation: DVx Inc.

Market Cap 11.86B 72.42M 63.61M 59.16M 54.28M 102M 6.97B 104M 702M 274M 3.43B 272M 266M P/E 2024
61.4x
P/E 2025 23.9x
Enterprise Value 6.81B 41.6M 36.54M 33.98M 31.18M 58.58M 4.01B 59.49M 403M 158M 1.97B 156M 153M EV / Sales 2024
0.05x
EV / Sales 2025 0.08x
Free-Float
27.8%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
President 49 2026-06-25
Director of Finance/CFO 52 2024-05-31
Corporate Officer/Principal 57 -
Director TitleAgeSince
Chairman 61 2026-06-25
Director/Board Member 52 2026-06-25
Director/Board Member 65 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.11%+0.42% - - 60.94M
+1.11%-2.68%+19.61%+7.08% 9.74B
+4.51%+5.73%+19.12%+10.30% 1.35B
-6.34%-9.05% - - 1.25B
+3.11%+1.45%+5.79%-9.85% 1.06B
-2.70%-5.72%+34.25%+16.27% 571M
-3.33%-6.54%-28.09%-55.05% 561M
+0.57%+0.28%-11.69%-10.30% 413M
-2.01%-10.32%+87.62%+125.36% 379M
+0.32%-9.51%-60.15%-83.56% 240M
Average -0.49%-4.03%+8.31%+0.03% 1.56B
Weighted average by Cap. +0.54%-3.24%+16.80%+5.16%

Financials

2024 2025
Net sales 45.85B 280M 246M 229M 210M 394M 26.97B 401M 2.72B 1.06B 13.26B 1.05B 1.03B 50.32B 307M 270M 251M 230M 433M 29.6B 440M 2.98B 1.16B 14.55B 1.15B 1.13B
Net income 172M 1.05M 923K 858K 788K 1.48M 101M 1.5M 10.19M 3.98M 49.75M 3.94M 3.86M 410M 2.5M 2.2M 2.05M 1.88M 3.53M 241M 3.58M 24.29M 9.49M 119M 9.4M 9.2M
Net Debt -7.48B -45.68M -40.12M -37.31M -34.24M -64.33M -4.4B -65.32M -443M -173M -2.16B -171M -168M -5.05B -30.83M -27.07M -25.18M -23.1M -43.41M -2.97B -44.08M -299M -117M -1.46B -116M -113M
Logo DVx Inc.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
Employees
334
Date Price Change Volume
26-07-27 JP¥949.00 -0.11% 1,700
26-07-24 JP¥950.00 +0.11% 4,800
26-07-23 JP¥949.00 -1.04% 1,900
26-07-22 JP¥959.00 +0.84% 1,700
26-07-21 JP¥951.00 +0.53% 2,200

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3079 Stock